Long‐Term Evaluation of Givinostat in Duchenne Muscular Dystrophy, and Natural History ComparisonsCraig M. McDonald, Claudio Bruno, Erika Finanger et al.|Annals of Clinical and Translational Neurology|2025Cited by 12
429P Givinostat in Duchenne muscular dystrophy: natural history comparison applying propensity score matchingC. McDonald, Valeria Sansone, H. Phan et al.|Neuromuscular Disorders|2024Cited by 1
20861. GIVINOSTAT EN DISTROFIA MUSCULAR DE DUCHENNE: COMPARACIÓN DE HISTORIA NATURAL APLICANDO PUNTUACIÓN DE PROPENSIÓNC. McDonald, Valeria Sansone, H. Phan et al.|Neurology Perspectives|2024Cited by 0
686VPThorough QT study on the effect of therapeutic and supratherapeutic dosing of givinostat in healthy volunteersTracey Willis, S. Cazzaniga, E. Mercuri et al.|Neuromuscular Disorders|2025Cited by 0